ENTRY       D08891                      Drug
NAME        Cintredekin besudotox (USAN/INN)
FORMULA     C2234H3512N650O682S10
EXACT_MASS  50677.7321
MOL_WEIGHT  50708.3849
SEQUENCE    MHSPGPVPPS TALRELIEEL VNITQNQKAP LCNGSMVWSI NLTAGMYCAA LESLINVSGC
            SAIEKTQRML SGFCPHKVSA GQFSSLHVRD TKIEVAQFVK DLLLHLKKLF REGRFNKASG
            GPEGGSLAAL TAHQACHLPL ETFTRHRQPR GWEQLEQCGY PVQRLVALYL AARLSWNQVD
            QVIRNALASP GSGGDLGEAI REQPEQARLA LTLAAAESER FVRQGTGNDE AGAANGPADS
            GDALLERNYP TGAEFLGDGG DVSFSTRGTQ NWTVERLLQA HRQLEERGYV FVGYHGTFLE
            AAQSIVFGGV RARSQDLDAI WRGFYIAGDP ALAYGYAQDQ EPDARGRIRN GALLRVYVPR
            SSLPGFYRTS LTLAAPEAAG EVERLIGHPL PLRLDAITGP EEEGGRLETI LGWPLAERTV
            VIPSAIPTDP RNVGGDLDPS SIPDQEQAIS ALPDYASQPG QPPREDLR
            (Disulfide bridge: 32-60, 48-74, 136-158)
  TYPE      Peptide
EFFICACY    Antineoplastic
COMMENT     interleukin 13 (IL13) [HSA:3596] [KO:K05435] analog
            Treatment of malignant glioma, including glioblastoma multiforme and anaplastic astrocytoma
DBLINKS     CAS: 372075-36-0
            PubChem: 96025574
///
